Antihypertensive drugs

https://www.inorganicventures.com/coa-sds-search

Algal chloroform-soluble extract.

Alimemazine Tartrate.

ALIQUAT 336

A nonpeptide renin inhibitor (IC₅₀ = 0.6 nM) that selectively binds to the S3 sub-pocket of renin, preventing the conversion of angiotensinogen to angiotensin I, thereby blocking eventual conversion to angiotensin II reduces blood

A nonpeptide renin inhibitor (IC₅₀ = 0.6 nM) that selectively binds to the S3 sub-pocket of renin, preventing the conversion of angiotensinogen to angiotensin I, thereby blocking eventual conversion to angiotensin II reduces blood

A nonpeptide renin inhibitor (IC₅₀ = 0.6 nM) that selectively binds to the S3 sub-pocket of renin, preventing the conversion of angiotensinogen to angiotensin I, thereby blocking eventual conversion to angiotensin II reduces blood

A nonpeptide renin inhibitor (IC₅₀ = 0.6 nM) that selectively binds to the S3 sub-pocket of renin, preventing the conversion of angiotensinogen to angiotensin I, thereby blocking eventual conversion to angiotensin II reduces blood

Biochem/physiol Actions Aliskiren hemifumarate (ALS) has been used to treat hypertension, alone or with other antihypertensive medications. It is suitable for oral administration.

Biochem/physiol Actions Aliskiren hemifumarate (ALS) has been used to treat hypertension, alone or with other antihypertensive medications. It is suitable for oral administration.

Aliskiren hemifumarate is a direct renin inhibitor with IC50 of 1.5 nM.

Aliskiren hemifumarate is a direct renin inhibitor with IC50 of 1.5 nM.